Showing 361-370 of 3714 results for "".
- Cabaletta Bio Receives FDA Fast Track Designation for DSG3-CAART for the Treatment of mPVhttps://practicaldermatology.com/news/cabaletta-bio-receives-fda-fast-track-designation-for-dsg3-caart-for-the-treatment-of-mpv/2460383/The U.S. Food and Drug Administration (FDA) granted Cabaletta Bio’s DSG3-CAART (Desmoglein 3 Chimeric AutoAntibody Receptor T cells) Fast Track Designation for improving healing of mucosal blisters in patients with mPV. DSG3-CAART is designed to specifically target the cause of mPV, B cells that e…
- Half of Lupus Rashes Harbor High Levels of Staph Bacteriahttps://practicaldermatology.com/news/half-of-lupus-rashes-harbor-high-levels-of-staph-bacteria/2460279/Fifty percent of skin rashes in patients with lupus contain an abnormally high presence of Staphylococcus aureus bacteria, according to a study in the Journal of Investigative Dermatology. In addition, researchers found that interferon increases the stickiness of staph aureus to their skin. “Bec…
- CSF Kicks Off in Nashvillehttps://practicaldermatology.com/news/csf-kicks-off-in-nashville/2460229/Cosmetic Surgery Forum (CSF), now in its 11th year, has kicked off in Nashville. It’s the meeting’s first time in the Music City, which allows for live injection sessions—a popular meeting highlight. The program covers everything from cannabidiol (CBD) in skincare and platelet-rich plasma (PRP) for…
- Norfolk Dermatologist Recognized for Increasing Accessibility for Patientshttps://practicaldermatology.com/news/norfolk-dermatologist-recognized-for-increasing-accessibility-for-patients/2460227/Dermatologist Abby Van Voorhees, MD, FAAD, is an American Academy of Dermatology Patient Care Hero for her leadership at the Rapid Access Clinic at the Eastern Virginia Medical School Dermatology Practice in Norfolk, Va. The Eastern Virginia Medical School Dermatology practice allows anyone with a…
- Industry News: Galderma Will Go It Alonehttps://practicaldermatology.com/news/industry-news-galderma-will-go-it-alone/2460161/It’s official. Galderma is going it alone after completion of CHF 10.2 billion acquisition of Nestlé Skin Health, first announced in May 2019. The acquisition, led by a consortium comprising the EQT VIII fund (“EQT”), Luxinva (a wholly-owned subsidiary of Abu Dhabi Investment Authority, “ADIA”), …
- AAD Honors Dr. Robert Brodell for Establishing Free Clinic in the Mississippi Deltahttps://practicaldermatology.com/news/aad-honors-dr-robert-brodell-for-establishing-free-clinic-in-the-delta/2459998/Robert T. Brodell, MD, FAAD, is an American Academy of Dermatology (AAD) Patient Care Hero for working with colleagues at the University of Mississippi Medical Center in Oxford to open a dermatology clinic in the Delta — an area of the state that previously did not have a dermatologist for nearly 1…
- AAD Announces 2019 Election Resultshttps://practicaldermatology.com/news/aad-announces-2019-election-results/2459967/The votes have been counted in the 2019 AAD Election, and the following candidates will take office at the conclusion of the 2020 Annual Meeting in Denver, Colorado on March 24, 2020. The President-Elect is Kenneth J. Tomecki, MD, FAAD and the Vice President-Elect is Neal Bhatia, MD, FAAD, who is …
- Leadership Changes Announced for Cuterahttps://practicaldermatology.com/news/leadership-changes-announced-for-cutera/2459944/Cutera, Inc.'s James Reinstein resigned as President, Chief Executive Officer, and member of its Board of Directors, effective immediately. The Board has appointed Cutera’s Chief Operating Officer, Jason Richey, as Interim CEO. J. Daniel Plants, Chairman of Cutera, said: “Cutera’s Board takes ser…
- New Study Seeks to Improve Skin Cancer Prevention in Young Adults Via a New Websitehttps://practicaldermatology.com/news/new-study-seeks-to-improve-skin-cancer-prevention-in-young-adults-via-a-new-website/2457539/Researchers out of Rutgers Cancer Institute of New Jersey and colleagues from across the country are conducting a study to evaluate the reach and effectiveness of an online program targeted at skin cancer prevention in young adults. Investigators are refining an existing website to help young adu…
- Cutanea Life Sciences Launches Xepi Creamhttps://practicaldermatology.com/news/cutanea-life-sciences-launches-xepi-cream-1/2457512/Cutanea Life Sciences, Inc. has launched Xepi™ (ozenoxacin) Cream, 1% for the treatment of impetigo in adult and pediatric patients two months of age or older. Xepi is a non-fluorinated topical quinolone indicated for the treatment of impetigo due to Staphylococcus aureusand/or Streptococcus pyogen…